Wanbury Ltd
Wanbury is engaged in the business of pharmaceutical and related activities, including research.
- Market Cap ₹ 254 Cr.
- Current Price ₹ 101
- High / Low ₹ 115 / 16.4
- Stock P/E
- Book Value ₹ -51.0
- Dividend Yield 0.00 %
- ROCE 31.1 %
- ROE %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 8.03% over past five years.
- Contingent liabilities of Rs.39133.28 Cr.
- Promoters have pledged 76.76% of their holding.
- Earnings include an other income of Rs.84.51 Cr.
- Debtor days have increased from 40.32 to 50.45 days.
- Company's cost of borrowing seems high
- Promoter holding has decreased over last 3 years: -4.03%
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
167 | 350 | 315 | 345 | 414 | 661 | 250 | 420 | 432 | 370 | 391 | 367 | 339 | |
189 | 312 | 302 | 337 | 398 | 620 | 228 | 387 | 414 | 438 | 375 | 344 | 327 | |
Operating Profit | -22 | 39 | 13 | 7 | 16 | 41 | 21 | 34 | 19 | -68 | 16 | 23 | 12 |
OPM % | -13% | 11% | 4% | 2% | 4% | 6% | 9% | 8% | 4% | -18% | 4% | 6% | 4% |
Other Income | 6 | 31 | 15 | 19 | 4 | -237 | 6 | 0 | 90 | 76 | 9 | 84 | 85 |
Interest | 11 | 29 | 41 | 33 | 31 | 48 | 19 | 32 | 36 | 31 | 40 | 33 | 28 |
Depreciation | 4 | 9 | 9 | 9 | 15 | 23 | 5 | 9 | 10 | 10 | 10 | 10 | 10 |
Profit before tax | -31 | 32 | -22 | -16 | -25 | -267 | 4 | -7 | 62 | -32 | -25 | 65 | 59 |
Tax % | -1% | 5% | -0% | 0% | -1% | -1% | 28% | 0% | 1% | 1% | 1% | 0% | |
Net Profit | -31 | 30 | -22 | -16 | -25 | -270 | 3 | -7 | 62 | -32 | -25 | 64 | 59 |
EPS in Rs | -21.29 | 20.37 | -15.16 | -9.29 | -14.66 | -135.21 | 1.61 | -3.52 | 26.71 | -13.49 | -10.48 | 25.79 | 23.50 |
Dividend Payout % | 0% | 5% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 8% |
3 Years: | -5% |
TTM: | -16% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -202% |
Stock Price CAGR | |
---|---|
10 Years: | 11% |
5 Years: | 13% |
3 Years: | 44% |
1 Year: | 359% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | 15 | 15 | 17 | 17 | 20 | 20 | 20 | 23 | 24 | 24 | 25 | 25 | |
Reserves | 102 | 170 | 140 | 123 | 97 | -186 | -188 | -195 | -151 | -183 | -207 | -143 | -153 |
Borrowings | 296 | 322 | 297 | 395 | 406 | 389 | 381 | 373 | 273 | 224 | 233 | 164 | 109 |
138 | 100 | 174 | 128 | 156 | 182 | 182 | 189 | 265 | 207 | 235 | 231 | 306 | |
Total Liabilities | 550 | 607 | 627 | 663 | 676 | 404 | 394 | 386 | 411 | 271 | 285 | 277 | 288 |
181 | 220 | 220 | 211 | 198 | 174 | 164 | 180 | 186 | 178 | 172 | 164 | 162 | |
CWIP | 15 | 15 | 10 | 13 | 21 | 13 | 19 | 14 | 10 | 10 | 9 | 14 | 13 |
Investments | 124 | 102 | 105 | 106 | 106 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
231 | 270 | 292 | 334 | 351 | 218 | 212 | 192 | 215 | 83 | 103 | 99 | 113 | |
Total Assets | 550 | 607 | 627 | 663 | 676 | 404 | 394 | 386 | 411 | 271 | 285 | 277 | 288 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
49 | 6 | 28 | -41 | 40 | 74 | 40 | 43 | 43 | 32 | 30 | 44 | |
-48 | -24 | -7 | -14 | -14 | -7 | -5 | -20 | -13 | -1 | -3 | 64 | |
13 | 4 | -21 | 57 | -22 | -75 | -30 | -28 | -27 | -33 | -27 | -108 | |
Net Cash Flow | 14 | -15 | 1 | 3 | 3 | -9 | 5 | -5 | 3 | -2 | -0 | -0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 13% | 4% | 2% | 1% | 6% | 13% | 57% | -1% | 26% | 31% | ||
Debtor Days | 183 | 86 | 76 | 84 | 74 | 57 | 144 | 65 | 71 | 29 | 41 | 50 |
Inventory Turnover | 4.72 | 4.75 | 4.62 | 5.64 | 9.16 | 5.88 | 6.27 | 8.01 | 13.00 | 12.10 |
Documents
Recent announcements
- Closure of Trading Window 31 Mar
- Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015) 22 Mar
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 22 Mar
- Shareholder Meeting / Postal Ballot-Outcome Of EGM 20 Mar
- Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Mar
View all
Annual reports
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse